The new year’s healthcare deals began to snowball as Sanofi and Celgene Corp. scooped up assets that promise to offset pricing pressure for some of their top-selling drugs. Within hours of each other Monday, the two drugmakers announced deals worth about $20 billion combined. French giant Sanofi...